Evidence map›Paper›PMID 29983254›Full record

ArticleVaccine2018

Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.

Kaan Z Apaydin, Holly B Fontenot, Christina P C Borba, Derri L Shtasel, Sharon Ulery, Kenneth H Mayer, Alex S Keuroghlian

Abstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kaan Z ApaydinThe Fenway Institute, United States.
Holly B FontenotThe Fenway Institute and Boston College, United States.
Christina P C BorbaBoston University, School of Medicine and Boston Medical Center, United States.
Derri L ShtaselHarvard Medical School and Massachusetts General Hospital, United States.
Sharon UleryThe Fenway Institute, United States.
Kenneth H MayerThe Fenway Institute, Beth Israel Deaconess Medical Center, United States.
Alex S KeuroghlianThe Fenway Institute, Harvard Medical School, and Massachusetts General Hospital, United States. Electronic address: akeuroghlian@partners.org.
Fenway Health · USBeth Israel Deaconess Medical Center · USBoston Medical Center · USHarvard University · USMassachusetts General Hospital · US

Funding

Epidemiological and socio-cultural landscape of schizophrenia in rural EthiopiaK01MH100428 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BORBA, CHRISTINA PAULA CABRAL · 2014 to 2018
$903k
NIMH NIH HHS K01 MH100428
6 · The paper itself

Abstract

backgroundDisparities in human papillomavirus (HPV) vaccination completion have been noted among sexual and gender minority (SGM) people. Little is known about factors associated with HPV vaccination among SGM people. This study examines factors linked with completion of HPV vaccination among SGM patients.

methodsWe collected cross-sectional data from electronic health records (EHRs) of SGM patients receiving primary care at a Boston community health center specialized in SGM health. We employed a binomial logistic regression model to identify factors associated with 3-dose HPV vaccine completion.

resultsPatients were 70.3% white, with mean age of 26.3 years (SD = 2.48), 26.9% identifying as gender minorities and 79% as sexual minorities, 48.9% with 4-year college or graduate degrees, 59.4% employed, 65.9% with private insurance, 39.1% living at or below the federal poverty level, and 8.3% living with HIV. Seventy-seven percent of patients who were offered HPV vaccination had completed the series. Factors significantly associated with HPV vaccine completion included: 4-year college or graduate degree (OR: 2.87; 95% CI = 1.26-6.53), completion of primary care appointments (OR: 1.03; 95% CI: 1.01-1.05), Hepatitis A or B vaccine completion (OR: 2.59; 95% CI: 1.2-5.59), and visits for a sexually transmitted infection (STI) screen (OR: 1.22; 95% CI: 1.03-1.43).

conclusionVaccine completion was higher among SGM with higher levels of education, Hepatitis A or B vaccination, and completed health visits. These findings highlight potential ways to increase HPV vaccination, such as offering tailored HPV vaccine education, bundling with other vaccines, and incorporating HPV vaccination with STI screenings.

Indexed as

Community Health CentersCross-Sectional StudiesFemaleHumansImmunization ProgramsLogistic ModelsMalePapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareVaccinationPapillomavirus VaccinesHPVHPV-related cancersHuman papillomavirusSexual and gender minorityTransgenderVaccine

Identifiers

PMID29983254
PMCPMC6130979
OpenAlexW2836789873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.